Vitamin D Treatment in Ulcerative Colitis

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Ulcerative Colitis, Inflammatory Bowel Disease

In brief

The purpose of this study is to test blood and tissue samples of people with Ulcerative Colitis (UC) to see what effects Vitamin D3 may have on the immune system. This research is being done because it could lead to the development of new treatment for people with Inflammatory Bowel Disease (IBD).

Key facts

Study ID

NCT01640496

Run by

University of Chicago

People needed

0

Starts

2012-07-01

Expected to finish

2014-12-01

Last updated by the study team

2014-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be over 18 years of age
• have a diagnosis of UC as confirmed by histology.
• UC patients must have active but mild disease as confirmed by a Mayo Clinic endoscopy score from 2-4,
• not requiring medication adjustment during the trial.
• Patients must be capable of understanding the purpose, risks and expectations of study participation and willing to provide written informed consent.

You may not qualify if…

• Individuals on vitamin D or laxative therapy (except for purposes of endoscopy preparation),
• UC patients with fulminant colitis or active C difficile or other colonic infections,
• age<18 year old,
• individuals with bleeding disorders will be excluded from the study.

Where it is running

• NorthShore — Evanston, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.